(Q36268487)

13 August 2017

title

Cellular response to tissue hypoxia and its involvement in disease progression (English)

1 reference

13 August 2017

0 references

Eiji Ikeda

1

1 reference

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

13 August 2017

published in

Pathology International

1 reference

13 August 2017

volume

55

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

603-610

1 reference

Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Cytoplasmic Domain of the Ubiquitous Na+/H+ Exchanger NHE1 Can Confer Ca2+ Responsiveness to the Apical Isoform NHE3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Signal transduction to hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The mammalian basic helix-loop-helix/PAS family of transcriptional regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

HIF-1 and tumor progression: pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Tumor hypoxia in pelvic recurrences of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia in tumors: molecular targets for anti-cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Intra-tumoural microvessel density in human solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Transcriptional regulation of vascular endothelial growth factor in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Expression of hypoxia-inducible factor 1? in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01877.X

10.1111/J.1440-1827.2005.01877.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference